======= NAGLU ======= == Gene Information == * **Official Symbol**: N/AGLU * **Official Name**: N-acetyl-alpha-glucosaminidase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4669|4669]] * **UniProt**: [[https://www.uniprot.org/uniprot/P54802|P54802]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NAGLU&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NAGLU|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609701|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes an enzyme that degrades heparan sulfate by hydrolysis of terminal N-acetyl-D-glucosamine residues in N-acetyl-alpha-D-glucosaminides. Defects in this gene are the cause of mucopolysaccharidosis type IIIB (MPS-IIIB), also known as Sanfilippo syndrome B. This disease is characterized by the lysosomal accumulation and urinary excretion of heparan sulfate. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Involved in the degradation of heparan sulfate. |NAGLU| |NAGLU C| |NAGLU N| |alpha-N-acetylglucosaminidase activity| |retinal rod cell development| |locomotor rhythm| |middle ear morphogenesis| |circadian behavior| |rhythmic behavior| |cerebellar Purkinje cell layer development| |eye photoreceptor cell development| |inner ear receptor cell development| |eye photoreceptor cell differentiation| |photoreceptor cell development| |cerebellar cortex development| |inner ear receptor cell differentiation| |photoreceptor cell differentiation| |mechanoreceptor differentiation| |lysosome organization| |lytic vacuole organization| |glycosaminoglycan catabolic process| |aminoglycan catabolic process| |lysosomal lumen| |cerebellum development| |metencephalon development| |ear morphogenesis| |vacuole organization| |circadian rhythm| |eye morphogenesis| |hindbrain development| |glycosaminoglycan metabolic process| |aminoglycan metabolic process| |carbohydrate derivative catabolic process| |inner ear development| |locomotory behavior| |ear development| |lysosome| |sensory organ morphogenesis| |rhythmic process| |embryonic organ morphogenesis| |eye development| |visual system development| |sensory system development| |embryonic organ development| |sensory organ development| |embryonic morphogenesis| |behavior| |brain development| |head development| |neuron development| |animal organ morphogenesis| |embryo development| |central nervous system development| |neuron differentiation| |carbohydrate derivative metabolic process| |macromolecule catabolic process| |organonitrogen compound catabolic process| |generation of neurons| |neurogenesis| |cell development| |organic substance catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp153|SGC2096 2.6μM R03 exp153]]|-1.74| |[[:results:exp218|A-395 10μM R05 exp218]]|1.83| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|1.89| |[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|1.91| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|1/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6432 * **Expression level (log2 read counts)**: 4.46 {{:chemogenomics:nalm6 dist.png?nolink |}}